Cancer Market Research Reports

RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct's, ‘Papillary Thyroid Cancer Pipeline Review, H2 2014', provides an overview of the Papillary Thyroid Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic developm...

$ 2000


Global Markets Direct's, ‘Hormone-Sensitive Prostate Cancer Pipeline Review, H2 2014', provides an overview of the Hormone-Sensitive Prostate Cancer's therapeutic pipeline.This report provides comprehensive information on the th...

$ 2000


Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine pancreatic cancer. When pancreatic cancer cells spread from the panc...

$ 2500


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 6995


Global Markets Direct's, ‘Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2014', provides an overview of the Cancer Therapeutics CRC Pty Ltd's pharmaceutical research and development focus.This report provides compre...

$ 1500


Global Markets Direct's, ‘Bile Duct Cancer (Cholangiocarcinoma) Pipeline Review, H2 2014', provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)'s therapeutic pipeline.This report provides comprehensive information o...

$ 2000


Global Markets Direct's, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Pipeline Review, H2 2014', provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)'s therapeu...

$ 2000


Global Markets Direct's, ‘Cancer Cachexia Pipeline Review, H2 2014', provides an overview of the Cancer Cachexia's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cancer Cac...

$ 2000


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


GlobalData has released its new PharmaPoint Drug Evaluation report, Herceptin (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most co...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Perjeta (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most comm...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Kadcyla (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most comm...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Tykerb (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most commo...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Neratinib (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most co...

$ 3495


Global Markets Direct's, ‘Head And Neck Cancer Squamous Cell Carcinoma Pipeline Review, H2 2014', provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma's therapeutic pipeline.This report provides comprehensive...

$ 2000


Global Markets Direct's, ‘Cancer Pain Pipeline Review, H2 2014', provides an overview of the Cancer Pain's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cancer Pain, compl...

$ 2000


The global ablation technologies market is estimated to grow at a CAGR of 9.6% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the ablation technologies market in 2014, the Asia-Pa...

$ 4650


Global Markets Direct's, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma Pipeline Review, H2 2014', provides an overview of the Recurrent Head And Neck Cancer Squamous Cell Carcinoma's therapeutic pipeline.This report pr...

$ 2000

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

> Live Chat
Live Chat by Comm100